Reference:
1. Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the
uterus–revisited. Am J Obstet Gynecol 1972;112:583-593.
2. Benagiano G, Brosens I. History of adenomyosis. Best Pract Res Clin
Obstet Gynaecol 2006;20:449-463.
3. Larsen SB, Lundorf E, Forman A, Dueholm M. Adenomyosis and junctional
zone changes in patients with endometriosis. Eur J Obstet Gynecol Reprod
Biol 2011;157:206-211.
4. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis
on quality of life and work productivity: a multicenter study across ten
countries. Fertil Steril 2011;96:366-373.e368.
5. Prescott J, Farland LV, Tobias DK, et al. A prospective cohort study
of endometriosis and subsequent risk of infertility. Hum Reprod
2016;31:1475-1482.
6. Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the
diagnosis and treatment of endometriosis. Hum Reprod 2005;20:2698-2704.
7. Kvaskoff M, Mahamat-Saleh Y, Farland LV, et al. Endometriosis and
cancer: a systematic review and meta-analysis. Hum Reprod Update
2021;27:393-420.
8. Liu L, Luo N, Guo J, Xie Y, Chen L, Cheng Z. Berberine inhibits
growth and inflammatory invasive phenotypes of ectopic stromal cells:
Imply the possible treatment of adenomyosis. J Pharmacol Sci
2018;137:5-11.
9. Xiang T, Fan Y, Li C, et al. DACT2 silencing by promoter CpG
methylation disrupts its regulation of epithelial-to-mesenchymal
transition and cytoskeleton reorganization in breast cancer cells.
Oncotarget 2016;7:70924-70935.
10. Leduc C, Etienne-Manneville S. Regulation of microtubule-associated
motors drives intermediate filament network polarization. J Cell Biol
2017;216:1689-1703.
11. Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes
Dev 2013;27:355-371.
12. Halon A, Donizy P, Surowiak P, Matkowski R. ERM/Rho protein
expression in ductal breast cancer: a 15 year follow-up. Cell Oncol
(Dordr) 2013;36:181-190.
13. Bo H, Gong Z, Zhang W, et al. Upregulated long non-coding RNA
AFAP1-AS1 expression is associated with progression and poor prognosis
of nasopharyngeal carcinoma. Oncotarget 2015;6:20404-20418.
14. Zeng Z, Bo H, Gong Z, et al. AFAP1-AS1, a long noncoding RNA
upregulated in lung cancer and promotes invasion and metastasis. Tumour
Biol 2016;37:729-737.
15. Tang Y, He Y, Zhang P, et al. LncRNAs regulate the cytoskeleton and
related Rho/ROCK signaling in cancer metastasis. Mol Cancer 2018;17:77.
16. Nan L, Yang L, Zheng Y, et al. Effects of Gualou Guizhi Decoction
Aqueous Extract on Axonal Regeneration in Organotypic Cortical Slice
Culture after Oxygen-Glucose Deprivation. Evid Based Complement Alternat
Med 2017;2017:5170538.
17. Lin J, Song Z, Chen X, et al. Trans-cinnamaldehyde shows
anti-depression effect in the forced swimming test and possible
involvement of the endocannabinoid system. Biochem Biophys Res Commun
2019;518:351-356.
18. Liu Z, Sun Z, Liu H, et al. Single-cell transcriptomic analysis of
eutopic endometrium and ectopic lesions of adenomyosis. Cell Biosci
2021;11:51.
19. Wang X, Shi Y, Xu L, et al. Traditional Chinese medicine
prescription Guizhi Fuling Pills in the treatment of endometriosis. Int
J Med Sci 2021;18:2401-2408.
20. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial
epithelial and stromal cells. Biol Reprod 2004;70:1738-1750.
21. Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in
transformation, metastasis and invasion. Cancer Metastasis Rev
2009;28:65-76.
22. Fan C, Qu H, Xiong F, et al. CircARHGAP12 promotes nasopharyngeal
carcinoma migration and invasion via ezrin-mediated cytoskeletal
remodeling. Cancer Lett 2021;496:41-56.
23. Henstra C, van Praagh J, Olinga P, Nagelkerke A. The
gastrointestinal microbiota in colorectal cancer cell migration and
invasion. Clin Exp Metastasis 2021;38:495-510.
24. Ciszewski WM, Wawro ME, Sacewicz-Hofman I, Sobierajska K.
Cytoskeleton Reorganization in EndMT-The Role in Cancer and Fibrotic
Diseases. Int J Mol Sci 2021;22.
25. Liu Y, Wang X, Wan L, et al. TIPE2 inhibits the migration and
invasion of endometrial cells by targeting β-catenin to reverse
epithelial-mesenchymal transition. Hum Reprod 2020;35:1377-1390.
26. Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family,
negatively regulates T cell immunity. Immunity 2003;18:849-861.
27. Darenfed H, Dayanandan B, Zhang T, Hsieh SH, Fournier AE, Mandato
CA. Molecular characterization of the effects of Y-27632. Cell Motil
Cytoskeleton 2007;64:97-109.
28. Zhang B. Guizhi Fuling pills inhibit the proliferation, migration
and invasion of human cutaneous malignant melanoma cells by regulating
the molecular axis of LncRNA TPT1-AS1 / miR-671-5p. Cell Mol Biol
(Noisy-le-grand) 2020;66:148-154.
29. Yao Z, Shulan Z. Inhibition effect of Guizhi-Fuling-decoction on the
invasion of human cervical cancer. J Ethnopharmacol 2008;120:25-35.
30. Chen D, Zhao J, Cong W. Chinese Herbal Medicines Facilitate the
Control of Chemotherapy-Induced Side Effects in Colorectal Cancer:
Progress and Perspective. Front Pharmacol 2018;9:1442.
31. Han L, Cao X, Chen Z, et al. Overcoming cisplatin resistance by
targeting the MTDH-PTEN interaction in ovarian cancer with sera derived
from rats exposed to Guizhi Fuling wan extract. BMC Complement Med Ther
2020;20:57.
32. Han L, Guo X, Bian H, et al. Guizhi Fuling Wan, a Traditional
Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian
Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway. Evid
Based Complement Alternat Med 2016;2016:4651949.
33. Lu CC, Shen CH, Chang CB, et al. Guizhi Fuling Wan as a Novel Agent
for Intravesical Treatment for Bladder Cancer in a Mouse Model. Mol Med
2016;22:64-73.
34. Dai Y, Qiang W, Yu X, et al. Guizhi Fuling Decoction inhibiting the
PI3K and MAPK pathways in breast cancer cells revealed by HTS(2)
technology and systems pharmacology. Comput Struct Biotechnol J
2020;18:1121-1136.
35. Jiang Y, Fan L. Evaluation of anticancer activities of Poria cocos
ethanol extract in breast cancer: In vivo and in vitro, identification
and mechanism. J Ethnopharmacol 2020;257:112851.
36. Bin J, Nie S, Tang Z, et al. Long noncoding RNA EPB41L4A-AS1
functions as an oncogene by regulating the Rho/ROCK pathway in
colorectal cancer. J Cell Physiol 2021;236:523-535.